Abstract
BackgroundPhosphorylated peptides presented by MHC molecules represent a new class of neoantigens expressed on cancer cells and recognized by CD8 T-cells. These peptides are promising targets for cancer immunotherapy. Previous...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have